NeuroSense Therapeutics, Ltd. - NRSN Net Assets per Single Share
The development of PrimeC combination therapy has provided a scientific breakthrough in the treatment of ALS for NeuroSense Therapeutics (NRSN). The final book value per share reflects asset dynamics, where 0.00 serves as the base parameter value. Growth prospects are linked to the drug's orphan status, although the lack of revenue and high clinical costs create significant risks of trial failure.
NeuroSense Therapeutics Ltd - analytical breakdowns and key metrics (NRSN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:neurosense-tx.com, NRSN
Book value per share determines the actual value of an investor's stake through the ratio of equity minus all liabilities to the number of securities. By analyzing the BVPS metric, one can assess the asset stability of NeuroSense Therapeutics (NRSN) amid Israel's geopolitical instability, where military conflicts create risks for the preservation of biomaterials and the conduct of clinical trials.
Competitor analysis for NeuroSense Therapeutics
Net Assets per Single Share BIIB (Biogen Corp)|NBIX: Net Assets per Share|Net Assets per Single Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share Praxis Precision Medicines (PRAX)|Equity per Share anavex.com|CeriBell - Book Value per Share|Net Asset Value per Share Prothena Corporation PRTA|Accounting Value per Share ALEC (Alector)|Annexon Biosciences Inc. - Book Value per Share|Net Assets per Single Share Omeros Corp. (OMER)|NGNE: Accounting Value of a Share|Net Assets per Single Share ACIU|VYGR (Voyager Therapeutics Inc) - Net Asset Value per Share|NMRA: Net Assets per Single Share|Net Assets per Share Scilex Holding Company, Inc.|Tevogen Bio Holdings - Book Value per Share|Net Asset Value per Share ACOG (alphacognition.com)|CGTX - Net Assets per Single Share|Inhibikase Therapeutics Inc - Equity per Share|Net Assets per Single Share SAVA (Cassava)|ASRT - Net Assets per Share|Book Value per Share COYA|Net Asset Value per Share Vistagen|OVID - Accounting Value per Share|Accounting Value of a Share Acumen Pharmaceuticals Inc. (ABOS)|Accounting Value per Share CervoMed Inc|Book Price of a Share alteritytherapeutics.com (ATHE)|Book Value per Share Clene|Accounting Value of a Share PepGen Inc PEPG|JUNS (Jupiter Neurosciences Inc) - Book Value per Share|RLMD: Net Asset Value per Share|Net Assets per Single Share Annovis Bio Corp ANVS|Grace Therapeutics (GRCE) - Accounting Value of a Share|AIFF (Firefly Neuroscience, Inc) - Book Value per Share|Book Value per Share KLTO|RVPH - Net Assets per Single Share|Share Book Value metaviatx.com (MTVA)|NRXS: Book Value per Share|HSDT - Net Asset Value per Share|Passage Bio Corp - Accounting Value per Share|Neuphoria Therapeutics Inc. (NEUP) - Book Value per Share|NERV - Accounting Value per Share|Athira Pharma Inc (ATHA) - Book Price of a Share|ADXN: Book Value per Share|Net Assets per Share Alzamend|Book Value per Share CYCN (Cyclerion Therapeutics)|Accounting Value per Share PTIX (protagenic.com)|Net Assets per Single Share KTTA|Cortigent Inc - Net Assets per Share|Avenue Therapeutics, Inc (ATXI) - Net Assets per Single Share|BCLI: Equity per Share|Net Assets per Single Share Cara Therapeutics, Inc. CARA|CHRO (chromocell.com) - Accounting Value of a Share|ELYM: Net Assets per Single Share|Net Assets per Share ITCI|Net Assets per Single Share Longboard Pharma LBPH|Equity per Share MRNS (Marinus Pharma)|NKGN - Net Assets per Single Share|Equity per Share neurobopharma.com NRBO|SAGE (Sage Therapeutics) - Book Value per Share|Synaptogenix Inc. (SNPX) - Net Asset Value per Share|TRVN: Accounting Value per Share|VIGL (Vigil Neuroscience, Inc.) - Book Value per Share|WENA - Net Assets per Single Share|Accounting Value of a Share CERE